HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

David A Hosford Selected Research

N- (2- (pyridin- 3- ylmethyl)- 1- azabicyclo(2.2.2)oct- 3- yl)- 1- benzofuran- 2- carboxamide

3/2016Phase 2 Trial of an Alpha-7 Nicotinic Receptor Agonist (TC-5619) in Negative and Cognitive Symptoms of Schizophrenia.
5/2013A randomized exploratory trial of an α-7 nicotinic receptor agonist (TC-5619) for cognitive enhancement in schizophrenia.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


David A Hosford Research Topics

Disease

2Schizophrenia (Dementia Praecox)
03/2016 - 05/2013
2Alzheimer Disease (Alzheimer's Disease)
03/2008 - 03/2004
1Neurobehavioral Manifestations
03/2016
1Cognitive Dysfunction
05/2013
1Hyperbilirubinemia
03/2004
1Pathologic Constriction (Stenosis)
03/2004
1Hypersensitivity (Allergy)
03/2004

Drug/Important Bio-Agent (IBA)

2Nicotinic Receptors (Nicotinic Acetylcholine Receptor)IBA
03/2016 - 05/2013
2N- (2- (pyridin- 3- ylmethyl)- 1- azabicyclo(2.2.2)oct- 3- yl)- 1- benzofuran- 2- carboxamideIBA
03/2016 - 05/2013
2Pharmaceutical PreparationsIBA
03/2008 - 03/2004
1Antipsychotic Agents (Antipsychotics)IBA
03/2016
1Risperidone (Risperdal Consta)FDA LinkGeneric
05/2013
1Quetiapine Fumarate (Seroquel)FDA Link
05/2013
1Reverse Transcriptase InhibitorsIBA
03/2004
1HLA-B57 antigenIBA
03/2004
1abacavir (Ziagen)FDA Link
03/2004
1ApolipoproteinsIBA
03/2004
1Apolipoproteins E (ApoE)IBA
03/2004
1tranilastIBA
03/2004
1NucleosidesIBA
03/2004
1Uridine Diphosphate (UDP)IBA
03/2004